The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. (Q51552450)
Jump to navigation
Jump to search
scientific article published in November 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. |
scientific article published in November 2000 |
Statements
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. (English)
1 reference
1 reference
Rosenfalck AM
1 reference
Maghsoudi S
1 reference
Fisker S
1 reference
Christiansen JS
1 reference
Hilsted J
1 reference
Vølund AA
1 reference
1 November 2000
1 reference
85
1 reference
11
1 reference
4173-4181
1 reference